Broadwood Capital Inc 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Broadwood Capital Inc disclosed 7 US equity positions worth $1.7bn in its Q4 2025 13F filing. The largest position was MNST at 38.0% of the reported book, followed by AXON and STAA. Against the Q3 2025 filing, it opened 0 new positions, added to 1 and reduced 2 among the top 7 holdings.
What did Broadwood Capital Inc own in Q4 2025? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | MNST MONSTER BEVERAGE CORP NEW | Consumer Defensive | 38.0% | $628.6m | 8,198,996 | -1% | reduced |
| 2 | AXON AXON ENTERPRISE INC | Industrials | 23.8% | $393.9m | 693,504 | 0% | held |
| 3 | STAA STAAR SURGICAL CO | Healthcare | 21.0% | $346.8m | 15,019,491 | 11% | added |
| 4 | IWM ISHARES TR | 7.1% | $116.9m | 474,920 | 0% | held | |
| 5 | IMDX INSIGHT MOLECULAR DIA INC | 5.2% | $85.6m | 11,410,100 | 0% | held | |
| 6 | LCTX LINEAGE CELL THERAPEUTICS IN | 5.0% | $82.8m | 49,560,992 | 0% | held | |
| 7 | SERINA THERAPEUTICS INC | 0.0% | $104.2k | 54,484 | -35% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.